ERNA

Eterna Therapeutics Inc. is a clinical-stage biopharmaceutical firm headquartered in Brooklyn, New York, dedicated to advancing pioneering immunotherapy solutions aimed at addressing critical unmet needs in cancer treatment. The company harnesses cutting-edge technology platforms alongside a robust research and development strategy to enhance patient outcomes and drive innovative therapeutic advancements. With a focus on strategic collaborations and a commitment to delivering revolutionary therapies, Eterna presents a compelling investment opportunity within the evolving biopharmaceutical landscape, appealing to institutional investors seeking growth in the oncology sector.